Tenax Therapeutics Inc (TENX)
3.56
-0.06
(-1.66%)
USD |
NASDAQ |
May 23, 16:00
3.52
-0.04
(-1.12%)
Pre-Market: 20:00
Tenax Therapeutics Price to Book Value: 0.5609 for May 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 23, 2024 | 0.5609 |
| May 22, 2024 | 0.5703 |
| May 21, 2024 | 0.5782 |
| May 20, 2024 | 0.5939 |
| May 17, 2024 | 0.5591 |
| May 16, 2024 | 0.5593 |
| May 15, 2024 | 0.5656 |
| May 14, 2024 | 0.5467 |
| May 13, 2024 | 0.5593 |
| May 10, 2024 | 0.5648 |
| May 09, 2024 | 0.5624 |
| May 08, 2024 | 0.5593 |
| May 07, 2024 | 0.5561 |
| May 06, 2024 | 0.5845 |
| May 03, 2024 | 0.605 |
| May 02, 2024 | 0.5971 |
| May 01, 2024 | 0.6144 |
| April 30, 2024 | 0.6144 |
| April 29, 2024 | 0.5782 |
| April 26, 2024 | 0.5482 |
| April 25, 2024 | 0.5672 |
| April 24, 2024 | 0.5609 |
| April 23, 2024 | 0.5514 |
| April 22, 2024 | 0.5609 |
| April 19, 2024 | 0.5719 |
| Date | Value |
|---|---|
| April 18, 2024 | 0.5798 |
| April 17, 2024 | 0.5656 |
| April 16, 2024 | 0.5687 |
| April 15, 2024 | 0.5679 |
| April 12, 2024 | 0.5924 |
| April 11, 2024 | 0.6097 |
| April 10, 2024 | 0.6097 |
| April 09, 2024 | 0.6176 |
| April 08, 2024 | 0.6254 |
| April 05, 2024 | 0.6018 |
| April 04, 2024 | 0.6018 |
| April 03, 2024 | 0.6475 |
| April 02, 2024 | 0.6097 |
| April 01, 2024 | 0.6018 |
| March 28, 2024 | 1.025 |
| March 27, 2024 | 0.9358 |
| March 26, 2024 | 0.8971 |
| March 25, 2024 | 0.8947 |
| March 22, 2024 | 0.9237 |
| March 21, 2024 | 0.9479 |
| March 20, 2024 | 0.931 |
| March 19, 2024 | 0.833 |
| March 18, 2024 | 0.8483 |
| March 15, 2024 | 0.8178 |
| March 14, 2024 | 0.833 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2151
Minimum
Feb 09 2024
35.74
Maximum
Jun 30 2021
4.457
Average
1.827
Median
Nov 17 2020
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 4.920 |
| IGC Pharma Inc | 3.450 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.904 |
Price to Book Value Related Metrics
| Price | 3.56 |
| Earnings Yield | -712.4% |
| Market Cap | 6.971M |